{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:24:30Z","timestamp":1794846270422,"version":"4.9.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Non-communicable diseases (NCDs) are a leading cause of maternal mortality and morbidity worldwide. The World Health Organization is developing new recommendations focusing on the management of NCDs for pregnant, intrapartum, and postnatal women. Thus, to support the development of new guidelines and recommendations, we aimed to determine the availability, focus, and scope of recommendations of current guidelines for the management of NCDs during pregnancy, intrapartum, and postnatal period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PubMed, Global Index Medicus, TRIP, and Guideline International Network databases were searched on 31 May 2021, to identify any NCD-related guidelines published between 2011 and 2021 with no language or country restrictions. Websites of 165 professional organizations were also searched. Characteristics of included guidelines were analyzed, and recommendations were extracted from guidelines of five high-priority NCD conditions (diabetes, chronic hypertension, respiratory conditions, hemoglobinopathies and sickle cell disease, and mental and substance use disorders).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 6026 citations and 165 websites, 405 guidelines were included of which 132 (33%) were pregnancy-specific and 285 (88%) were developed in high-income countries. Among pregnancy-specific guidelines, the most common conditions for which recommendations were provided were gestational diabetes, circulatory diseases, thyroid disorders, and hypertensive disorders of pregnancy. For the five high-priority conditions, 47 guidelines were identified which provided 1834 recommendations, largely focused on antenatal care interventions (62%) such as early detection, screening tools, pharmacological treatment, and lifestyle education. Postnatal recommendations largely covered postnatal clinical assessments, lifestyle education, and breastfeeding. Health system recommendations largely covered multidisciplinary care teams and strengthening referral pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study provides a robust assessment of currently available guidelines and mapping of recommendations on NCD management within maternal health services, which will inform the scope of the World Health Organization\u2019s future guideline development activities. This study identified a need to develop guidelines that consider NCDs holistically, with an integrated approach to antenatal, intrapartum, and postnatal care, and that are relevant for resource-limited contexts. Any such guidelines should consider what interventions are most essential to improving outcomes for women with NCDs and their newborns, and how variations in quality of NCD-related care can be addressed.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12916-022-02508-9","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:02:42Z","timestamp":1663632162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevention and control of non-communicable diseases in antenatal, intrapartum, and postnatal care: a systematic scoping review of clinical practice guidelines since 2011"],"prefix":"10.1186","volume":"20","author":[{"given":"Jenny","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshreena K.","family":"Karwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"2508_CR1","unstructured":"Barnes SB, Ramanarayanan D, Amin N. The unseen side of pregnancy: non-communicable diseases and maternal health. https:\/\/www.wilsoncenter.org\/sites\/default\/files\/media\/uploads\/documents\/TheUnseenSideofPregnancy.pdf. Accessed 01 May 2022."},{"key":"2508_CR2","unstructured":"NCD Alliance. Noncommunicable diseases: a priority for women\u2019s health and development. https:\/\/ncdalliance.org\/sites\/default\/files\/resource_files\/Non%20Communicable%20Diseases%20A%20priority%20for%20womens%27s%20health%20and%20development.pdf. Accessed 01 May 2022."},{"issue":"2","key":"2508_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ijgo.13198","volume":"150","author":"A Kapur","year":"2020","unstructured":"Kapur A, Hod M. Maternal health and non-communicable disease prevention: an investment case for the post COVID-19 world and need for better health economic data. Int J Gynaecol Obstet. 2020;150(2):151\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"2508_CR4","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41569-020-0390-z","volume":"17","author":"KP Ramlakhan","year":"2020","unstructured":"Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol. 2020;17(11):718\u201331.","journal-title":"Nat Rev Cardiol"},{"key":"2508_CR5","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice G","year":"2011","unstructured":"Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice G. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011."},{"issue":"4","key":"2508_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/ijerph18041454","volume":"18","author":"J Mussa","year":"2021","unstructured":"Mussa J, Meltzer S, Bond R, Garfield N, Dasgupta K. Trends in national Canadian guideline recommendations for the screening and diagnosis of gestational diabetes mellitus over the years: a scoping review. Int J Environ Res Public Health. 2021;18(4):1454.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"2508_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/HJH.0000000000000069","volume":"32","author":"KA Al Khaja","year":"2014","unstructured":"Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32(3):454\u201363.","journal-title":"J Hypertens"},{"issue":"4","key":"2508_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/17446651.2017.1338944","volume":"12","author":"I Khan","year":"2017","unstructured":"Khan I, Okosieme O, Lazarus J. Antithyroid drug therapy in pregnancy: a review of guideline recommendations. Expert Rev Endocrinol Metab. 2017;12(4):269\u201378.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"2508_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"2508_CR10","unstructured":"World Health Organization. International classification of health interventions (ICHI). https:\/\/www.who.int\/standards\/classifications\/international-classification-of-health-interventions. Accessed 01 May 2022."},{"key":"2508_CR11","unstructured":"World Health Organization. WHO methods and data sources for country-level causes of death 2000-2019. https:\/\/www.who.int\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5. Accessed 01 May 2022."},{"key":"2508_CR12","unstructured":"World Health Organization, United Nations Population Fund, World Bank, United Nations Children's Fund (UNICEF). Pregnancy, childbirth, postpartum and newborn care: A guide for essential practice (3rd edition). https:\/\/www.who.int\/publications\/i\/item\/9789241549356. Accessed 01 May 2022."},{"key":"2508_CR13","unstructured":"Canada's Drug and Health Technology Agency (CADTH). Strings attached: CADTH database search filters. https:\/\/www.cadth.ca\/strings-attached-cadths-database-search-filters. Accessed 22 Dec 2021."},{"key":"2508_CR14","unstructured":"Veritas Health Innovation. Covidence systematic review software. www.covidence.org. Accessed 01 Jul 2021."},{"key":"2508_CR15","unstructured":"Ministry of Labor Health and Social Welfare. Cardiovascular disease management during pregnancy. http:\/\/www.goga.org.ge\/img\/%E1%83%99%E1%83%90%E1%83%A0%E1%83%93%E1%83%98%E1%83%9D%E1%83%95%E1%83%90%E1%83%A1%E1%83%99%E1%83%A3%E1%83%9A%E1%83%A3%E1%83%A0%E1%83%92%E1%83%90%E1%83%98%E1%83%93%E1%83%9A%E1%83%90%E1%83%98%E1%83%9C%E1%83%98.pdf. Accessed 01 May 2022."},{"issue":"4","key":"2508_CR16","first-page":"227","volume":"55","author":"Hypertensive Disorders in Pregnancy Subgroup - Chinese Society of Obstetrics and Gynecology\/Chinese Medical Association","year":"2020","unstructured":"Hypertensive Disorders in Pregnancy Subgroup - Chinese Society of Obstetrics and Gynecology\/Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China. Zhonghua Fu Chan Ke Za Zhi. 2020;55(4):227\u201338.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"6","key":"2508_CR17","first-page":"401","volume":"51","author":"Obstetrics Subgroup - Chinese Society of Obstetrics and Gynocology\/Chinese Medical Association","year":"2016","unstructured":"Obstetrics Subgroup - Chinese Society of Obstetrics and Gynocology\/Chinese Medical Association. Expert consensus document of the diagnosis and treatment of pregnancy with heart disease. Zhonghua Fu Chan Ke Za Zhi. 2016;51(6):401\u20139.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2508_CR18","unstructured":"Ministry of Health Malaysia. Heart Disease in Pregnancy. https:\/\/www.malaysianheart.org\/files\/583aacd86e27d.pdf. Accessed 01 May 2022."},{"issue":"9","key":"2508_CR19","first-page":"12723","volume":"109","author":"J Moodley","year":"2019","unstructured":"Moodley J, Soma-Pillay P, Buchmann E, Pattinson RC. Hypertensive disorders in pregnancy: 2019 National guideline. S Afr Med J. 2019;109(9):12723.","journal-title":"S Afr Med J"},{"key":"2508_CR20","unstructured":"The Royal Thai College of Obstetricians and Gynaecologists. Managment of Hypertensive Disorders in Pregnancy. http:\/\/www.rtcog.or.th\/home\/wp-content\/uploads\/2020\/10\/OB-63-021_Management-of-Hypertensive-Disorders-in-Pregnancy07Oct20.pdf. Accessed 01 May 2022."},{"issue":"7 Suppl","key":"2508_CR21","first-page":"55","volume":"62","author":"V Seshiah","year":"2014","unstructured":"Seshiah V, Banerjee S, Balaji V, Muruganathan A, Das AK. Consensus evidence-based guidelines for management of gestational diabetes mellitus in India. J Assoc Physicians India. 2014;62(7 Suppl):55\u201362.","journal-title":"J Assoc Physicians India"},{"key":"2508_CR22","unstructured":"The Royal Thai College of Obstetricians and Gynaecologists. Diabetes Mellitus Screening in Pregnancy. http:\/\/www.rtcog.or.th\/home\/wp-content\/uploads\/2017\/05\/OB-010_Diabetes-meltitus-screeing-in-pregnancy.pdf. Accessed 01 May 2022."},{"issue":"8","key":"2508_CR23","first-page":"561","volume":"49","author":"Obstetrics Subgroup - Chinese Society of Obstetrics and Gynecology\/Chinese Medical Association, Group of Pregnancy with Diabetes Mellitus - Chinese Society of Perinatal Medicine\/Chinese Medical Association","year":"2014","unstructured":"Obstetrics Subgroup - Chinese Society of Obstetrics and Gynecology\/Chinese Medical Association, Group of Pregnancy with Diabetes Mellitus - Chinese Society of Perinatal Medicine\/Chinese Medical Association. Diagnosis and therapy guideline of pregnancy with diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi. 2014;49(8):561\u20139.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2508_CR24","unstructured":"Ministry of Health Malaysia. Management of Diabetes in Pregnancy. https:\/\/www.moh.gov.my\/moh\/resources\/Penerbitan\/CPG\/Endocrine\/1a.pdf. Accessed 01 May 2022."},{"key":"2508_CR25","unstructured":"Ministry of Labor Health and Social Welfare. Management of gestational diabetes. https:\/\/www.moh.gov.ge\/uploads\/guidelines\/2017\/06\/01\/88ccc5e850b980e984bd653c3b854778.pdf. Accessed 01 May 2022."},{"issue":"5","key":"2508_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.reuma.2014.12.004","volume":"11","author":"M\u00c1 Saavedra Salinas","year":"2015","unstructured":"Saavedra Salinas M\u00c1, Barrera Cruz A, Cabral Casta\u00f1eda AR, Jara Quezada LJ, Arce-Salinas CA, \u00c1lvarez Nemegyei J, et al. Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part II. Reumatol Clin. 2015;11(5):305\u201315.","journal-title":"Reumatol Clin"},{"issue":"9","key":"2508_CR27","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.jand.2018.03.014","volume":"118","author":"MO Duarte-Gardea","year":"2018","unstructured":"Duarte-Gardea MO, Gonzales-Pacheco DM, Reader DM, Thomas AM, Wang SR, Gregory RP, et al. Academy of Nutrition and Dietetics Gestational Diabetes Evidence-Based Nutrition Practice Guideline. J Acad Nutr Diet. 2018;118(9):1719\u201342.","journal-title":"J Acad Nutr Diet"},{"issue":"2","key":"2508_CR28","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"The American College of Obstetricians and Gynecologists","year":"2018","unstructured":"The American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49\u201364.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2508_CR29","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1210\/jc.2013-2465","volume":"98","author":"I Blumer","year":"2013","unstructured":"Blumer I, Hadar E, Hadden DR, Jovanovi\u010d L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(11):4227\u201349.","journal-title":"J Clin Endocrinol Metab"},{"key":"2508_CR30","unstructured":"World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. https:\/\/apps.who.int\/iris\/handle\/10665\/85975. Accessed 01 Jul 2021."},{"key":"2508_CR31","unstructured":"Government of South Australia. Gestational diabetes and diabetes mellitus. https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/146238004ee2144cb404bdd150ce4f37\/Diabetes+Mellitus+and+Gestational+Diabetes_July2015.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-146238004ee2144cb404bdd150ce4f37-mhbYUex. Accessed 01 Jul 2021."},{"issue":"7","key":"2508_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0034-1366412","volume":"122","author":"H Kleinwechter","year":"2014","unstructured":"Kleinwechter H, Sch\u00e4fer-Graf U, B\u00fchrer C, Hoesli I, Kainer F, Kautzky-Willer A, et al. Gestational diabetes mellitus (GDM) diagnosis, therapy and follow-up care: Practice Guideline of the German Diabetes Association(DDG) and the German Association for Gynaecologyand Obstetrics (DGGG). Exp Clin Endocrinol Diabetes. 2014;122(7):395\u2013405.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2508_CR33","unstructured":"Asociaci\u00f3n Latinoamericana de Diabetes. Gu\u00edas de diagn\u00f3stico y tratamiento de la diabetes gestacional. https:\/\/www.entrerios.gov.ar\/msalud\/wp-content\/uploads\/2013\/05\/publicacion-guias-dg-alad_v6_n4_155-169-4.pdf. Accessed 01 Jul 2021."},{"issue":"12","key":"2508_CR34","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.jogc.2019.03.008","volume":"41","author":"H Berger","year":"2019","unstructured":"Berger H, Gagnon R, Sermer M. Guideline No. 393-Diabetes in Pregnancy. J Obstet Gynaecol Can. 2019;41(12):1814\u201325.","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl 3","key":"2508_CR35","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/S0020-7292(15)30033-3","volume":"131","author":"M Hod","year":"2015","unstructured":"Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173\u2013211.","journal-title":"Int J Gynaecol Obstet"},{"key":"2508_CR36","unstructured":"Joint British Diabetes Societies for Inpatient Care (JBDS\u2013IP). Management of glycaemic control in pregnant women with diabetes on obstetric wards and delivery units. https:\/\/www.diabetes.org.uk\/resources-s3\/2017-10\/JBDS%20Pregnancy%202017%2020.10.17_0.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR37","unstructured":"National Collaborating Centre for Women's Children's Health. In: National Institute for Health and Care Excellence: clinical guidelines. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: National Institute for Health and Care Excellence (UK); 2015."},{"issue":"6","key":"2508_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.7326\/M13-2905","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(6):414\u201320.","journal-title":"Ann Intern Med"},{"key":"2508_CR39","unstructured":"Ministry of Health (New Zealand). Screening, diagnosis and management of gestational diabetes in New Zealand: a clinical practice guideline. https:\/\/www.health.govt.nz\/system\/files\/documents\/publications\/screening-diagnosis-management-of-gestational-diabetes-in-nz-clinical-practive-guideline-dec14-v2.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5354\/2735-7996.2015.71353","volume":"26","author":"Hospital Cl\u00ednico Universidad de Chile","year":"2015","unstructured":"Hospital Cl\u00ednico Universidad de Chile. Serie gu\u00edas cl\u00ednicas: diabetes y embarazo (1\u00aa parte): cuidado preconcepcional, diagn\u00f3stico y seguimiento. Rev Hosp Cl\u00edn Univ Chile. 2015;26:348\u201358.","journal-title":"Rev Hosp Cl\u00edn Univ Chile"},{"issue":"6","key":"2508_CR41","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","volume":"132","author":"American College of Gynecologists and Obstetricians","year":"2018","unstructured":"American College of Gynecologists and Obstetricians. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstet Gynecol. 2018;132(6):e228\u201348.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2508_CR42","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ajo.12399","volume":"55","author":"SA Lowe","year":"2015","unstructured":"Lowe SA, Bowyer L, Lust K, McMahon LP, Morton M, North RA, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55(5):e1\u201329.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"7-8 Pt 1","key":"2508_CR43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.lpm.2016.05.012","volume":"45","author":"C Mounier-Vehier","year":"2016","unstructured":"Mounier-Vehier C, Amar J, Boivin JM, Denolle T, Fauvel JP, Plu-Bureau G, et al. Hypertension and pregnancy. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. Presse Med. 2016;45(7-8 Pt 1):682\u201399.","journal-title":"Presse Med"},{"issue":"5","key":"2508_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cjca.2018.02.021","volume":"34","author":"S Butalia","year":"2018","unstructured":"Butalia S, Audibert F, C\u00f4t\u00e9 AM, Firoz T, Logan AG, Magee LA, et al. Hypertension Canada\u2019s 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol. 2018;34(5):526\u201331.","journal-title":"Can J Cardiol"},{"issue":"1","key":"2508_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertension."},{"issue":"7-8","key":"2508_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.33963\/KP.14904","volume":"77","author":"A Prejbisz","year":"2019","unstructured":"Prejbisz A, Dobrowolski P, Kosi\u0144ski P, Bomba-Opo\u0144 D, Adamczak M, Bekiesi\u0144ska-Figatowska M, et al. Management of hypertension in pregnancy: prevention, diagnosis, treatment and long-term prognosis. Kardiol Pol. 2019;77(7-8):757\u2013806.","journal-title":"Kardiol Pol"},{"issue":"1","key":"2508_CR47","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","volume":"133","author":"American College of Obstetrics and Gynecologists","year":"2019","unstructured":"American College of Obstetrics and Gynecologists. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26\u201350.","journal-title":"Obstet Gynecol"},{"key":"2508_CR48","unstructured":"Royal College of Physicians of Ireland (RCPI). The management of hypertension in pregnancy. https:\/\/rcpi-live-cdn.s3.amazonaws.com\/wp-content\/uploads\/2017\/02\/Hypertension-Guideline_approved_120716-1.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR49","unstructured":"Swedish Society of Obstetrics and Gynecology. Riktlinjer f\u00f6r hypertonisjukdomar under graviditet. https:\/\/www.sfog.se\/media\/337263\/hypertonisjukdomar-under-graviditet-sfog-2019-10-23-reviderad-210121.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR50","unstructured":"Government of South Australia. Asthma in Pregnancy. https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/ea28ed004ee1da8eacbeadd150ce4f37\/Asthma-pregnancy-WCHN-PPG-20052012.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-ea28ed004ee1da8eacbeadd150ce4f37-nxzd1bA. Accessed 01 Jul 2021."},{"key":"2508_CR51","volume-title":"National Institute for Health and Care Excellence: Clinical Guidelines. Intrapartum care for women with existing medical conditions or obstetric complications and their babies","author":"National Guideline Alliance","year":"2019","unstructured":"National Guideline Alliance. National Institute for Health and Care Excellence: Clinical Guidelines. Intrapartum care for women with existing medical conditions or obstetric complications and their babies. London: National Institute for Health and Care Excellence (UK); 2019."},{"key":"2508_CR52","unstructured":"Royal College of Obstetricians and Gynaecologists. Management of Sickle Cell Disease in Pregnancy. https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/gtg_61.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR53","unstructured":"beyondblue. Depression and related disorders \u2013 anxiety, bipolar disorder and puerperal psychosis \u2013 in the perinatal period. A guideline for primary care health professionals. https:\/\/cope.org.au\/wp-content\/uploads\/2013\/12\/Perinatal-Mental-Health-Clinical-Practice-Guidelines.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR54","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of perinatal mood disorders. https:\/\/www.sign.ac.uk\/assets\/sign127_update.pdf. Accessed 01 Jul 2021."},{"key":"2508_CR55","unstructured":"BC Reproductive Mental Health Program. Best Practice Guidelines for Mental Health Disorders in the Perinatal Period. http:\/\/www.perinatalservicesbc.ca\/Documents\/Guidelines-Standards\/Maternal\/MentalHealthDisordersGuideline.pdf. Accessed 01 Jul 2021."},{"issue":"8","key":"2508_CR56","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1701-2163(15)30180-8","volume":"37","author":"N Fleming","year":"2015","unstructured":"Fleming N, O'Driscoll T, Becker G, Spitzer RF. Adolescent Pregnancy Guidelines. J Obstet Gynaecol Can. 2015;37(8):740\u201356.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"2508_CR57","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/15622975.2015.1009163","volume":"16","author":"A Hasan","year":"2015","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenth\u00f8j B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015;16(3):142\u201370.","journal-title":"World J Biol Psychiatry"},{"key":"2508_CR58","unstructured":"The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Substance use in pregnancy. https:\/\/ranzcog.edu.au\/RANZCOG_SITE\/media\/RANZCOG-MEDIA\/Women%27s%20Health\/Statement%20and%20guidelines\/Clinical-Obstetrics\/Substance-use-in-pregnancy-(C-Obs-55)-March-2018.pdf?ext=.pdf. Accessed 01 Jul 2021."},{"issue":"1","key":"2508_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.wombi.2011.12.001","volume":"26","author":"MP Austin","year":"2013","unstructured":"Austin MP, Middleton P, Reilly NM, Highet NJ. Detection and management of mood disorders in the maternity setting: the Australian Clinical Practice Guidelines. Women Birth. 2013;26(1):2\u20139.","journal-title":"Women Birth"},{"key":"2508_CR60","unstructured":"Government of South Australia. Anxiety and depression in the perinatal period. https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/c7c0ccf9-b704-4411-9b47-fbf777ac0829\/Anxiety+and+Depression+in+the+Perinatal+Period_PPG_v1_0.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-c7c0ccf9-b704-4411-9b47-fbf777ac0829-nGzKLbc. Accessed 01 Jul 2021."},{"key":"2508_CR61","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 757: Screening for Perinatal Depression. Obstet Gynecol. 2018;132(5):e208\u201312.","DOI":"10.1097\/AOG.0000000000002927"},{"key":"2508_CR62","unstructured":"Registered Nurses\u2019 Association of Ontario. Assessment and Interventions for Perinatal Depression. https:\/\/rnao.ca\/bpg\/guidelines\/assessment-and-interventions-perinatal-depression. Accessed 01 Jul 2021."},{"issue":"6","key":"2508_CR63","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jama.2019.0007","volume":"321","author":"SJ Curry","year":"2019","unstructured":"Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(6):580\u20137.","journal-title":"JAMA."},{"issue":"2","key":"2508_CR64","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","volume":"130","author":"American College of Obstetricians and Gynecologists","year":"2017","unstructured":"American College of Obstetricians and Gynecologists. Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstet Gynecol. 2017;130(2):e81\u201394.","journal-title":"Obstet Gynecol"},{"key":"2508_CR65","unstructured":"Government of South Australia. Substance use in Pregnancy. https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/fad90e004eede261b572b76a7ac0d6e4\/Substance+use+in+pregnancy_May2014.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-fad90e004eede261b572b76a7ac0d6e4-n5j0wVl. Accessed 01 Jul 2021."},{"key":"2508_CR66","volume-title":"Antenatal and postnatal mental health: clinical management and service guidance","author":"National Institute for Health and Care Excellence (NICE)","year":"2014","unstructured":"National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance. London: National Institute for Health and Care Excellence (NICE); 2014."},{"key":"2508_CR67","unstructured":"World Health Organization. Guidelines for identification and management of substance use and substance use disorders in pregnancy. https:\/\/www.who.int\/publications\/i\/item\/9789241548731. Accessed 01 Jul 2021."},{"issue":"10","key":"2508_CR68","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jogc.2017.04.028","volume":"39","author":"A Ordean","year":"2017","unstructured":"Ordean A, Wong S, Graves L. No. 349-Substance Use in Pregnancy. J Obstet Gynaecol Can. 2017;39(10):922\u2013937.e922.","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"2508_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/15622975.2018.1510185","volume":"20","author":"F Thibaut","year":"2019","unstructured":"Thibaut F, Chagraoui A, Buckley L, Gressier F, Labad J, Lamy S, et al. WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women. World J Biol Psychiatry. 2019;20(1):17\u201350.","journal-title":"World J Biol Psychiatry"},{"issue":"9","key":"2508_CR70","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jogc.2020.03.002","volume":"42","author":"L Graves","year":"2020","unstructured":"Graves L, Carson G, Poole N, Patel T, Bigalky J, Green CR, et al. Guideline No. 405: Screening and counselling for alcohol consumption during pregnancy. J Obstet Gynaecol Can. 2020;42(9):1158\u20131173.e1151.","journal-title":"J Obstet Gynaecol Can"},{"key":"2508_CR71","unstructured":"British Columbia Centre on Substance Use (BCCSU). Pregnancy Supplement \u2013 Provincial Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder. https:\/\/www.bccsu.ca\/wp-content\/uploads\/2021\/03\/Pregnancy-Supplement-Provincial-Guideline-for-the-Clinical-Management-of-High-Risk-Drinking-and-Alcohol-Use-Disorder.pdf. Accessed 01 Jul 2021."},{"issue":"10053","key":"2508_CR72","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/S0140-6736(16)31467-2","volume":"388","author":"GBD SDG Collaborators","year":"2016","unstructured":"GBD SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1813\u201350.","journal-title":"Lancet."},{"key":"2508_CR73","unstructured":"United Nations. Transforming our world: the 2030 agenda for sustainable development. https:\/\/sdgs.un.org\/2030agenda. Accessed 08 Dec 2021."},{"key":"2508_CR74","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0140-6736(21)02550-2","volume":"398","author":"SI Lee","year":"2021","unstructured":"Lee SI, Azcoaga-Lorenzo A, Agrawal U, Kennedy JI, Fagbamigbe AF, Hope H, et al. Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a cross-sectional study. Lancet. 2021;398:S7.","journal-title":"Lancet."},{"issue":"6","key":"2508_CR75","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tun\u00e7alp \u00d6, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u201333.","journal-title":"Lancet Glob Health"},{"key":"2508_CR76","unstructured":"The George Institute for Global Health India. High-risk pregnancy and non-communicable diseases in India. https:\/\/www.georgeinstitute.org.in\/sites\/default\/files\/smarthealth_pregnancy_workshops.pdf. Accessed 01 Jul 2021."},{"issue":"1","key":"2508_CR77","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12978-020-0857-8","volume":"17","author":"S Yaya","year":"2020","unstructured":"Yaya S, Reddy KS, Beliz\u00e1n JM, Pingray V. Non-communicable diseases and reproductive health in sub-Saharan Africa: bridging the policy-implementation gaps. Reprod Health. 2020;17(1):8.","journal-title":"Reprod Health"},{"issue":"2","key":"2508_CR78","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.chest.2020.09.260","volume":"159","author":"A Tabyshova","year":"2021","unstructured":"Tabyshova A, Hurst JR, Soriano JB, Checkley W, Wan-Chun Huang E, Trofor AC, et al. Gaps in COPD guidelines of low- and middle-income countries: a systematic scoping review. Chest. 2021;159(2):575\u201384.","journal-title":"Chest."},{"issue":"6","key":"2508_CR79","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1161\/HYPERTENSIONAHA.116.08290","volume":"68","author":"M Owolabi","year":"2016","unstructured":"Owolabi M, Olowoyo P, Miranda JJ, Akinyemi R, Feng W, Yaria J, et al. Gaps in hypertension guidelines in low- and middle-income versus high-income countries: a systematic review. Hypertension. 2016;68(6):1328\u201337.","journal-title":"Hypertension."},{"key":"2508_CR80","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jns.2017.02.040","volume":"375","author":"H Bayona","year":"2017","unstructured":"Bayona H, Owolabi M, Feng W, Olowoyo P, Yaria J, Akinyemi R, et al. A systematic comparison of key features of ischemic stroke prevention guidelines in low- and middle-income vs. high-income countries. J Neurol Sci. 2017;375:360\u20136.","journal-title":"J Neurol Sci"},{"issue":"5","key":"2508_CR81","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2337\/dc17-1795","volume":"41","author":"MO Owolabi","year":"2018","unstructured":"Owolabi MO, Yaria JO, Daivadanam M, Makanjuola AI, Parker G, Oldenburg B, et al. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care. 2018;41(5):1097\u2013105.","journal-title":"Diabetes Care"},{"key":"2508_CR82","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.5888\/pcd15.170397","volume":"15","author":"LK Admon","year":"2018","unstructured":"Admon LK, Winkelman TNA, Heisler M, Dalton VK. Obstetric outcomes and delivery-related health care utilization and costs among pregnant women with multiple chronic conditions. Prev Chronic Dis. 2018;15:E21.","journal-title":"Prev Chronic Dis"},{"issue":"10056","key":"2508_CR83","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/S0140-6736(16)31472-6","volume":"388","author":"S Miller","year":"2016","unstructured":"Miller S, Abalos E, Chamillard M, Ciapponi A, Colaci D, Comand\u00e9 D, et al. Beyond too little, too late and too much, too soon: a pathway towards evidence-based, respectful maternity care worldwide. Lancet. 2016;388(10056):2176\u201392.","journal-title":"Lancet."},{"issue":"6","key":"2508_CR84","first-page":"903","volume":"30","author":"T Seyoum","year":"2020","unstructured":"Seyoum T, Alemayehu M, Christensson K, Lindgren H. Client factors affect provider adherence to guidelines during first antenatal care in public health facilities, Ethiopia: a multi-center cross-sectional study. Ethiop J Health Sci. 2020;30(6):903\u201312.","journal-title":"Ethiop J Health Sci"},{"issue":"1","key":"2508_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/jpm-2020-0343","volume":"49","author":"CM Escobar","year":"2020","unstructured":"Escobar CM, Gr\u00fcnebaum A, Nam EY, Olson AT, Anzai Y, Benedetto-Anzai MT, et al. Non-adherence to labor guidelines in cesarean sections done for failed induction and arrest of dilation. J Perinat Med. 2020;49(1):17\u201322.","journal-title":"J Perinat Med"},{"issue":"3","key":"2508_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230459","volume":"15","author":"S Millington","year":"2020","unstructured":"Millington S, Arstall M, Dekker G, Magarey J, Clark R. Adherence to clinical practice guidelines for South Australian pregnant women with cardiac conditions between 2003 and 2013. PLoS One. 2020;15(3):e0230459.","journal-title":"PLoS One"},{"issue":"18","key":"2508_CR87","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839\u201342.","journal-title":"CMAJ."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02508-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02508-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02508-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T06:10:18Z","timestamp":1701065418000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02508-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2508"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02508-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require ethical approval as this was a scoping review of publicly available clinical practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study did not use individual person\u2019s data in any form and did not require consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}